Lapatinib Terminated Phase 2 Trials for Malignancies Treatment

TerminatedTreatment2 IdentifierTitleDrugs
NCT02294786Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
NCT00447226Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists